JP2021528479A5 - - Google Patents

Info

Publication number
JP2021528479A5
JP2021528479A5 JP2021500230A JP2021500230A JP2021528479A5 JP 2021528479 A5 JP2021528479 A5 JP 2021528479A5 JP 2021500230 A JP2021500230 A JP 2021500230A JP 2021500230 A JP2021500230 A JP 2021500230A JP 2021528479 A5 JP2021528479 A5 JP 2021528479A5
Authority
JP
Japan
Prior art keywords
alkyl group
pharmaceutically acceptable
pharmaceutical composition
substituted
pharmaceutical product
Prior art date
Application number
JP2021500230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021528479A (ja
JPWO2020007698A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/067127 external-priority patent/WO2020007698A1/en
Publication of JP2021528479A publication Critical patent/JP2021528479A/ja
Publication of JPWO2020007698A5 publication Critical patent/JPWO2020007698A5/ja
Publication of JP2021528479A5 publication Critical patent/JP2021528479A5/ja
Ceased legal-status Critical Current

Links

JP2021500230A 2018-07-06 2019-06-27 ヤヌスキナーゼ阻害剤としての新規アミノ−イミダゾピリミジン誘導体およびその製薬学的用途 Ceased JP2021528479A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18182186.9 2018-07-06
EP18182186 2018-07-06
PCT/EP2019/067127 WO2020007698A1 (en) 2018-07-06 2019-06-27 Novel amino-imidazopyrimidine derivatives as janus kinase inhibitors and pharmaceutical use thereof

Publications (3)

Publication Number Publication Date
JP2021528479A JP2021528479A (ja) 2021-10-21
JPWO2020007698A5 JPWO2020007698A5 (https=) 2022-06-22
JP2021528479A5 true JP2021528479A5 (https=) 2022-06-22

Family

ID=62874761

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021500230A Ceased JP2021528479A (ja) 2018-07-06 2019-06-27 ヤヌスキナーゼ阻害剤としての新規アミノ−イミダゾピリミジン誘導体およびその製薬学的用途

Country Status (5)

Country Link
US (1) US20210269447A1 (https=)
EP (1) EP3818060B1 (https=)
JP (1) JP2021528479A (https=)
CN (1) CN112384514A (https=)
WO (1) WO2020007698A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022002210A1 (zh) * 2020-07-02 2022-01-06 南京明德新药研发有限公司 嘧啶并吡咯基类氘代化合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723340B2 (en) * 2005-01-13 2010-05-25 Signal Pharmaceuticals, Llc Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
EP2523957A1 (en) 2010-01-12 2012-11-21 F. Hoffmann-La Roche AG Tricyclic heterocyclic compounds, compositions and methods of use thereof
EP2518070A1 (en) * 2011-04-29 2012-10-31 Almirall, S.A. Pyrrolotriazinone derivatives as PI3K inhibitors
EP2518071A1 (en) * 2011-04-29 2012-10-31 Almirall, S.A. Imidazopyridine derivatives as PI3K inhibitors
EP2527344A1 (en) * 2011-05-25 2012-11-28 Almirall, S.A. Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
WO2013007765A1 (en) 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Fused tricyclic compounds for use as inhibitors of janus kinases
WO2013007768A1 (en) * 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
CN104918945B (zh) 2012-11-01 2018-01-05 因赛特公司 作为jak抑制剂的三环稠合噻吩衍生物
CN104936959B (zh) * 2013-03-08 2018-09-18 中国人民解放军军事医学科学院放射与辐射医学研究所 2,6,9-三取代嘌呤衍生物及其制备方法与应用
PL3568396T3 (pl) * 2017-01-11 2021-05-31 Leo Pharma A/S Nowe pochodne aminoimidazopirydyny jako inhibitory kinaz janusowych i ich zastosowanie farmaceutyczne

Similar Documents

Publication Publication Date Title
RU2019125177A (ru) Новые производные амино-имидазопиридина в качестве ингибиторов янус-киназы и их фармацевтическое применение
JP2012532112A5 (https=)
JP2024063143A5 (https=)
JP2013545730A5 (https=)
HRP20171848T1 (hr) Upotreba malononitrilamida za neuropatsku bol
IL314873A (en) Compositions and methods for treating disorders ameliorated by muscarnic receptor activation
JP2021525729A5 (https=)
JP2014502641A5 (https=)
JP2024069192A5 (https=)
JP2020504186A5 (https=)
RU2019121667A (ru) Аминопиразолы в качестве селективных ингибиторов янус-киназы
IL287470B1 (en) Derivatives of 6-methyl-6,1-dihydro-7H-pyrrolo[3,2-c]pyridin-7-one or of an acceptable pharmaceutical salt thereof and pharmaceutical preparations containing them.
JPWO2019160057A5 (https=)
RU2015112914A (ru) Бензимидазолы в качестве активных агентов для центральной нервной системы
JP2015500223A5 (https=)
MX2011010732A (es) Pirimidinas sustituidas por imidazol utiles en el tratamiento de trastornos relacionados con glucogeno sintasa cinasa 3 como la enfermedad de alzheimer.
JP2022116304A (ja) 血液がんの治療のためのPPARγアゴニスト
JP2009513713A5 (https=)
US20220096475A1 (en) Method for treating sarcoidosis-associated pulmonary hypertension
US20220047594A1 (en) Method for treating interstitial lung disease
JP2021528479A5 (https=)
JP2014513130A5 (https=)
RU2015120651A (ru) Производные имидазопиридина
RU2018130097A (ru) Лечение экземы кистей
JP2022514799A5 (https=)